# LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese Males

> **NCT05603598** · NA · UNKNOWN · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** LEAP-2 Protein, Human

## Key facts

- **NCT ID:** NCT05603598
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-24
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05603598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05603598, "LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese Males". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05603598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*